Concepedia

Peter Gerondelis

PG

7

Publications

321

Citations

7

H-Index

1995

Active since

Affiliations

University of Rochester(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United States)

Bipar

Institute of Molecular Biology and Biophysics

Peter Gerondelis is an author at University of Rochester specializing in hiv, medicine, and combination therapy.

Top concepts

Publications per year

1995–2014

7

Publications

7

Mutants of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Demonstrate Altered Rates of RNase H Cleavage That Correlate with HIV-1 Replication Fitness in Cell Culture

Richard Archer, Carrie Dykes, Peter Gerondelis et al. · Journal of Virology · 2000 · 101 citations · Full text

The P236L Delavirdine-Resistant Human Immunodeficiency Virus Type 1 Mutant Is Replication Defective and Demonstrates Alterations in both RNA 5′-End- and DNA 3′-End-Directed RNase H Activities

Peter Gerondelis, Richard Archer, Chockalingam Palaniappan et al. · Journal of Virology · 1999 · 86 citations · Full text

HIV-1 Drug Susceptibilities and Reverse Transcriptase Mutations in Patients Receiving Combination Therapy with Didanosine and Delavirdine

Lisa M. Demeter, Patricia M. Meehan, Gene D. Morse et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1997 · 39 citations

, , +14

Development of Zidovudine Resistance Mutations in Patients Receiving Prolonged Didanosine Monotherapy

Lisa M. Demeter, Tayyab Nawaz, Gene D. Morse et al. · The Journal of Infectious Diseases · 1995 · 36 citations

Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation

Greg L. Beilhartz, Marianne Ngure, Brian A. Johns et al. · Journal of Biological Chemistry · 2014 · 28 citations · Full text

Rows per page

1–5 of 7